Reduction in medical errors is a major focus of the US health system as it faces its largest restructuring in history. The emphasis on error reduction follows several revealing reports from the Institute of Medicine estimating the number of errors and resulting morbidity and mortality in US hospitals. The motivation for reducing medical errors is increased patient satisfaction as well as large reduction in healthcare costs. Therefore, automation (i.e., integrating, streamlining, and coordinating through technology) of the many processes within medical institutions should be a national priority.
Within laboratories, there are many sequential processes that must occur flawlessly to prevent errors. However, error rates in clinical laboratories have been estimated to be around 1%, which doesn't come close to an ideal goal of 1 error per million events, or a wellknown quality concept called Six Sigma, which is 3.4 errors per million events. Many clinical laboratory errors occur in the sample receipt and preparation process, also known as accessioning (1, 2 ) . Specimen accessioning errors may be attributed to many factors including improper labeling at the time of collection, inadequate vial filling, or selection of an inappropriate vial (e.g., citrate vs EDTA to prevent clotting). Collectively, these are considered phlebotomy errors. Additional errors may occur when reading the specimen information and determining if the specimen is appropriate for analysis (e.g., if it was transported on ice, if required). Even when all the previous parameters are within acceptable specifications, the specimen may have inherent patient-specific issues such as excessive icterus, lipemia, or hemolysis. Well-trained accessioners can identify most of these quality issues by careful inspection and by comparing what test was ordered by the physician to the specimen they are currently inspecting. However, in busy laboratories there is not always sufficient time to perform a thorough inspection of each specimen, and judgment can be clouded by inexperience and/or operator fatigue.
Automation and robotics has been a boon to clinical laboratories ever since the pioneering work of Dr. Masahide Sasaki (3, 4 ) . Laboratory automation provides relief from many routine laboratory tasks while improving quality, throughput, and patient safety (5 ). Although automation was originally applied to mechanical tasks such as specimen sorting, conveyor transportation, centrifugation, analysis, and storage, there were also some early attempts at the automation of sample inspection. The first published reference to automation of preanalytical inspection of medical specimens was in a patent filed in 1996 by Cadell and Samsoondar (6 ) . This invention was a method and apparatus for identifying the volume of liquid in the specimen vial as well as potential interferents such as hemoglobin (from red cell hemolysis), lipids (turbidity from lipemia), and bilirubin (icterus). The apparatus used light-emitting diodes positioned across a well in which a specimen was placed to find the serum or plasma volume, and then this information was used to position a fiber optic connection to a spectrophotometer to measure the concentrations of potentially interfering substances. Although this system did not read bar codes or human-readable text, it was the first technological solution that allowed automation of the determination of a few quality factors in medical specimens. In 2006, the first attempts were made to use machine vision and spectrophotometry together to read bar codes, decipher human-readable text, and determine icterus, hemolysis, and lipemia in serum through up to 3 specimen labels placed on top of each other in a closed-tube specimen (5 ). In 2001, Markin's laboratory developed a fiber optic-based charge-coupled device to determine hemolysis in specimens in a capped blood vial through specimen labels (7 ) . Inspired by these early research efforts, sample inspectors were built into several preanalytical processing robots that were on the market in the early 2000s, namely the Tecan FE500 (10 ), Pathfinder (Ai Scientific, Australia), and systems from Beckman Coulter and Olympus. However, these systems were principally designed to read bar codes and determine the height of the interface between the serum/plasma over the formed ele-ment pellet. In 2005, Acquired Data Systems (9 ) also used a fiber optic-based spectrophotometric detection system that made measurements through an open tube from the top to detect hemolysis and lipemia. However, there are major benefits from reading many quality metrics through a closed tube during accessioning, since such metrics can be gathered at the earliest possible time point after delivery to the laboratory. The preanalytical processor produced by Probenverteiltechnik quantified hemolysis, lipemia, and icterus as long as the label coverage left a 7-mm window through which to make measurements.
Once improper specimens enter the analytical laboratory, they take up valuable technologist time and consume analytical reagents that generate unreportable and unbillable results. Therefore, the sooner specimen errors can be determined in the preanalytical process, the sooner remedial measures may be taken such as automated special specimen handling or the ordering of a fresh specimen. Time is of the essence for requesting a replacement specimen since patients may be in the process of being discharged from the medical facility or may be waiting for analytical results before being admitted to surgery. The automation vendors are responding to these needs by incorporating increasingly sophisticated specimen inspection technologies in their preanalytical automation systems.
The paper by Hawker et al. in this issue of Clinical Chemistry (11 ) describes a novel engineering approach to read the specimen label using optical character recognition (OCR) to compare the patient name in the laboratory information system record to the patient name printed on the customer's label. In an impressive validation study involving the review of over 1 million images, the authors showed that the OCR system eventually could prevent patient name-mislabeled specimens when installed in the laboratory automation system. Interestingly, only 75% of the labels were passed as error free by the automated machine vision system. When visually checked, human operators found that the machine vision system classified all of these labels correctly as having a readable name that matched the computer record. Human inspection was still required for the 25% of labels that were flagged as having errors. Of these, 0.01% were found to be mislabeled and 0.01% to have misspelled names. The question remains as to what was wrong with the 25% of specimens that were failed by this automated system. Apparently, there are challenges with the complexity of the software required to read nonstandard fonts, misaligned labels, and truncated names and deal with many other inconsistencies in customer label quality. One opportunity for improving the performance of this OCR system as well as label quality in all laboratories is through implementation of the new CLSI Standard AUTO12-A for standardization of label formats (10 ) . There are other improvements to the system the authors believe will help reduce the 25% of labels that required human inspection but did not have actual errors. Machine vision has advanced in the 18 years since it was first applied to sample inspection. Hawker et al. have demonstrated clearly the great promise for a machine vision system using 4 integrated 5-megapixel cameras and sophisticated software to reduce the undetected error rate to Six Sigma levels and possibly beyond. Furthermore, their integration of a laboratory robot with a 3-axis gripper has demonstrated the opportunity to reduce operator fatigue as well. Additional progress in automated accessioning represents a great opportunity not only to improve patient safety, but to also reduce manual specimen processing time.
Automation has become a routine technology in clinical laboratories all over the world. However, the work of Hawker et al. demonstrates that there are still many opportunities for automation to help handle some of the more complex aspects of clinical laboratory testing. 
